• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Don't spit into the wind . . .

Article

Still using CT and MR imaging to evaluate head and neck cancers? That's so last millennium. Salivary transcriptome profiling-or spit-is the diagnostic tool for the 21st century.

Still using CT and MR imaging to evaluate head and neck cancers? That's so last millennium. Salivary transcriptome profiling-or spit-is the diagnostic tool for the 21st century.

Using the RNA in saliva, Dr. Li Yang and colleagues at the University of California, Los Angeles differentiated head and neck cancer patients from a group of healthy subjects based on biomarkers found in their spittle. The researchers achieved 91% sensitivity and specificity (Clinical Cancer Research 2004:10;8442-8450).

Although saliva contains the same biomarkers for disease that are found in blood, they are present at much lower levels of magnitude. Nanotechnology now allows scientists to manipulate materials on an atomic or molecular scale, thus revealing the components of saliva.

Researchers hope the techniques will work for other diseases such as breast cancer.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.